Acadian Asset Management’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-47,079
| Closed | -$1.19M | – | 1745 |
|
|
2023
Q1 | $1.19M | Sell |
47,079
-15,751
| -25% | -$399K | 0.01% | 837 |
|
|
2022
Q4 | $948K | Buy |
62,830
+2,153
| +4% | +$32.5K | ﹤0.01% | 859 |
|
|
2022
Q3 | $760K | Buy |
60,677
+4,935
| +9% | +$61.8K | ﹤0.01% | 873 |
|
|
2022
Q2 | $545K | Buy |
55,742
+777
| +1% | +$7.6K | ﹤0.01% | 949 |
|
|
2022
Q1 | $914K | Buy |
54,965
+10,492
| +24% | +$174K | ﹤0.01% | 848 |
|
|
2021
Q4 | $1.13M | Buy |
44,473
+15,131
| +52% | +$384K | ﹤0.01% | 804 |
|
|
2021
Q3 | $1.31M | Buy |
29,342
+8,093
| +38% | +$362K | 0.01% | 775 |
|
|
2021
Q2 | $859K | Buy |
21,249
+6,766
| +47% | +$274K | ﹤0.01% | 974 |
|
|
2021
Q1 | $770K | Sell |
14,483
-2,199
| -13% | -$117K | ﹤0.01% | 1034 |
|
|
2020
Q4 | $668K | Buy |
16,682
+54
| +0.3% | +$2.16K | ﹤0.01% | 1130 |
|
|
2020
Q3 | $948K | Buy |
16,628
+3,332
| +25% | +$190K | ﹤0.01% | 928 |
|
|
2020
Q2 | $981K | Buy |
13,296
+3,985
| +43% | +$294K | ﹤0.01% | 971 |
|
|
2020
Q1 | $462K | Buy |
9,311
+5,610
| +152% | +$278K | ﹤0.01% | 977 |
|
|
2019
Q4 | $284K | Buy |
+3,701
| New | +$284K | ﹤0.01% | 1207 |
|
|
2019
Q3 | – | Sell |
-3,294
| Closed | -$111K | – | 1884 |
|
|
2019
Q2 | $111K | Sell |
3,294
-441
| -12% | -$14.9K | ﹤0.01% | 1355 |
|
|
2019
Q1 | $198K | Sell |
3,735
-331
| -8% | -$17.5K | ﹤0.01% | 1355 |
|
|
2018
Q4 | $191K | Hold |
4,066
| – | – | ﹤0.01% | 1126 |
|
|
2018
Q3 | $358K | Sell |
4,066
-260
| -6% | -$22.9K | ﹤0.01% | 959 |
|
|
2018
Q2 | $450K | Buy |
4,326
+2,301
| +114% | +$239K | ﹤0.01% | 915 |
|
|
2018
Q1 | $162K | Buy |
+2,025
| New | +$162K | ﹤0.01% | 1111 |
|